Itraconazole-enhanced vindesine neurotoxicity in adult acute lymphoblastic leukaemia

Am J Hematol. 2007 Oct;82(10):942. doi: 10.1002/ajh.20918.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antifungal Agents / adverse effects*
  • Antifungal Agents / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Combined Modality Therapy
  • Cyclophosphamide / administration & dosage
  • Dexamethasone / administration & dosage
  • Doxorubicin / administration & dosage
  • Drug Synergism
  • Fatal Outcome
  • Female
  • Hematopoietic Stem Cell Transplantation
  • Humans
  • Idarubicin / administration & dosage
  • Intestinal Pseudo-Obstruction / chemically induced*
  • Itraconazole / adverse effects*
  • Itraconazole / therapeutic use
  • Male
  • Peripheral Nervous System Diseases / chemically induced*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / surgery
  • Prednisolone / administration & dosage
  • Vincristine / administration & dosage
  • Vindesine / administration & dosage
  • Vindesine / adverse effects*

Substances

  • Antifungal Agents
  • Itraconazole
  • Vincristine
  • Dexamethasone
  • Doxorubicin
  • Cyclophosphamide
  • Prednisolone
  • Vindesine
  • Idarubicin

Supplementary concepts

  • CVAD protocol
  • DVP regimen